Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance.

MLA

Shee, Kevin, et al. “Determining Long-Term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance.” European Urology Oncology, Sept. 2024. EBSCOhost, https://doi.org/10.1016/j.euo.2024.09.008.

APA

Shee, K., Nie, J., Cowan, J. E., Wang, L., Washington, S. L., 3rd, Shinohara, K., Nguyen, H. G., Cooperberg, M. R., & Carroll, P. R. (2024). Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance. European Urology Oncology. https://doi.org/10.1016/j.euo.2024.09.008

Chicago

Shee, Kevin, James Nie, Janet E Cowan, Lufan Wang, Samuel L Washington 3rd, Katsuto Shinohara, Hao G Nguyen, Matthew R Cooperberg, and Peter R Carroll. 2024. “Determining Long-Term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance.” European Urology Oncology, September. doi:10.1016/j.euo.2024.09.008.